Size Doesn’t Matter: A Small Biotech Plays Big with Payer Engagement
The complex, costly, and continuously evolving arena of biopharmaceutical product development demands a constant eye on commercialization potential. Continue Reading
payers
Payer Contact in a “Contactless” World: Achieving Early Engagement
In the first of a two-part series on early engagement with payers, Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Allen Lising, Managing Director of FormularyDecisions at Xcenda to discusss this innovative platform. Continue Reading
Reducing market access risk: how digital technology is strengthening strategies
Developing innovative pharmaceutical products is a lengthy process with no guarantee of success at the end. Manufacturers struggle with coordinating strategy internally and incorporating multiple payer requirements in clinical development programs. In the fourth of her five-part series on digital… Continue Reading
The things you need to know about the digital transformation of primary research
In the rapidly evolving market access landscape, it’s important to quickly identify current payer perspectives to determine future trends. High-quality, rapid primary research can be key to fast-forwarding your strategy. Continue Reading
Payer and HTA submissions: how digital technology is transforming market access processes
In the first of her five-part series on digital transformation in market access, Dr Patti Peeples, CEO of HealthEconomics.com, sits down with Claire Chadwick, HTA Manager at PRMA Consulting. Continue Reading
